These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19502566)

  • 1. Compound management beyond efficiency.
    Burr I; Winchester T; Keighley W; Sewing A
    J Biomol Screen; 2009 Jun; 14(5):485-91. PubMed ID: 19502566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient and effective compound management to support lead optimization.
    Johnson CW; Chatterjee M; Kubala S; Helm D; Houston J; Banks M
    J Biomol Screen; 2009 Jun; 14(5):523-30. PubMed ID: 19483145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innovation leading the way: application of lean manufacturing to sample management.
    Allen M; Wigglesworth MJ
    J Biomol Screen; 2009 Jun; 14(5):515-22. PubMed ID: 19483142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving lead generation success through integrated methods: transcending 'drug discovery by numbers'.
    Campbell JB
    IDrugs; 2010 Dec; 13(12):874-9. PubMed ID: 21154146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portfolio management in early stage drug discovery - a traveler's guide through uncharted territory.
    Betz UA
    Drug Discov Today; 2011 Jul; 16(13-14):609-18. PubMed ID: 21600301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons learned from candidate drug attrition.
    Empfield JR; Leeson PD
    IDrugs; 2010 Dec; 13(12):869-73. PubMed ID: 21154145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-quality cost-effective compound management support for HTS.
    Zaragoza-Sundqvist M; Eriksson H; Rohman M; Greasley PJ
    J Biomol Screen; 2009 Jun; 14(5):509-14. PubMed ID: 19487769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in improving the quality and flexibility of compound management.
    Janzen WP; Popa-Burke IG
    J Biomol Screen; 2009 Jun; 14(5):444-51. PubMed ID: 19483148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Driving external chemistry optimization via operations management principles.
    Bi FC; Frost HN; Ling X; Perry DA; Sakata SK; Bailey S; Fobian YM; Sloan L; Wood A
    Drug Discov Today; 2014 Mar; 19(3):289-94. PubMed ID: 23973340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug discovery: new models for industry-academic partnerships.
    Tralau-Stewart CJ; Wyatt CA; Kleyn DE; Ayad A
    Drug Discov Today; 2009 Jan; 14(1-2):95-101. PubMed ID: 18992364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case study: technology initiative led to advanced lead optimization screening processes at Bristol-Myers Squibb, 2004-2009.
    Zhang L; Cvijic ME; Lippy J; Myslik J; Brenner SL; Binnie A; Houston JG
    Drug Discov Today; 2012 Jul; 17(13-14):733-40. PubMed ID: 22425710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug discovery management, small is still beautiful: Why a number of companies get it wrong.
    Knutsen LJ
    Drug Discov Today; 2011 Jun; 16(11-12):476-84. PubMed ID: 21504798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ask the experts: the challenges and benefits of flow chemistry to optimize drug development.
    Anderson N; Gernaey KV; Jamison TF; Kircher M; Wiles C; Leadbeater NE; Sandford G; Richardson P
    Future Med Chem; 2012 Sep; 4(14):1779-89. PubMed ID: 23043475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability through the ages: the GSK experience.
    Blaxill Z; Holland-Crimmin S; Lifely R
    J Biomol Screen; 2009 Jun; 14(5):547-56. PubMed ID: 19470717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs for Neglected Diseases initiative model of drug development for neglected diseases: current status and future challenges.
    Ioset JR; Chang S
    Future Med Chem; 2011 Sep; 3(11):1361-71. PubMed ID: 21879842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality by design in lead optimization: a new strategy to address productivity in drug discovery.
    Rossi T; Braggio S
    Curr Opin Pharmacol; 2011 Oct; 11(5):515-20. PubMed ID: 21652263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does process excellence handcuff drug development?
    Koenig J
    Drug Discov Today; 2011 May; 16(9-10):377-81. PubMed ID: 21349347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Six Sigma: not for the faint of heart.
    Benedetto AR
    Radiol Manage; 2003; 25(2):40-53. PubMed ID: 12800564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How development and manufacturing will need to be structured--heads of development/manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Nepveux K; Sherlock JP; Futran M; Thien M; Krumme M
    J Pharm Sci; 2015 Mar; 104(3):850-64. PubMed ID: 25630721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.